Fairmount Funds Management LLC Merus N.V. Transaction History

Fairmount Funds Management LLC

  • $615 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$20.06 - $28.66 $23.4 Million - $33.4 Million
-1,164,091 Reduced 61.88%
717,254 $19.7 Million
Q3 2023

Nov 14, 2023
BUY
$20.13 - $27.29 $8.03 Million - $10.9 Million
398,940 Added 26.91%
1,881,345 $44.4 Million
Q2 2023

Aug 14, 2023
BUY
$18.33 - $27.18 $20.3 Million - $30.1 Million
1,107,970 Added 295.9%
1,482,405 $39 Million
Q1 2023

May 15, 2023
BUY
$14.25 - $20.5 $5.34 Million - $7.68 Million
374,435 New
374,435 $6.89 Million

Others Institutions Holding MRUS

# of Institutions
200
Shares Held
61.9M
Call Options Held
243K
Put Options Held
300K
View Full List

About Merus N.V.

MRUS Quotes by TradingView
  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.28B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Fairmount Funds Management LLC Portfolio

Follow Fairmount Funds Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairmount Funds Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fairmount Funds Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email